LeafNLP Demos
Back to explore

Report #2876898

Received Dec 8, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Dec 2, 2025
Onset
Dec 2, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKZ012112—

Symptoms (2)

No adverse eventWrong product administered

Symptom narrative

No Additional AE; patient inadvertently received PROQUAD instead of MMRII.; This spontaneous report was received from a Consumer or other non health professional and refers to a specified patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-Dec-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Z012112 with valid expiration date reported as 19-Jan-2027) 0.5 mL (route of administration and vaccination site were not reported) administered for prophylaxis. The vaccine was reconstituted with sterile diluent, solution for injection (lot # and expiration date were not reported). The patient inadvertently received Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) instead of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live lyophilisate and solvent for solution for injection (M-M-R II) (wrong product administered). Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was stored in the refrigerator in Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live lyophilisate and solvent for solution for injection (M-M-R II) carton box (unknown time frame and temperature). No symptoms were reported. No Additional adverse event (AE) or product quality complaint (PQC) was reported (no adverse event).

Other medications

Sterile diluent